Latest Drugwonks' Blog

The depths to which Barack Obama stooped to distance himself from the elements of his own health care proposal was astounding. No mandates or taxes on small businesses? No price controls on insurance companies (just making sure they pay their claims and cover what they say they cover)? I won't even go into the distortion of the claim that McCain proposes "eliminating" state regulation of insurance companies any more than Obama does by setting up a national marketplace.

Then he keeps on claiming he can reduce premiums by $2500. An exaggeration that is on the verge of a lie... Half of that is supposed to come from costs generated fromo electronic health records! But his estimate of "savings" from EHRs is based on productivity gains which themselves are estimates drawn from private sector examples in the auto industry over ten years. The other amount comes from "disease managment" savings achieved by getting doctors to practice guideline driven medicine. That's called rationing. Also unlikely. And even David Cutler, one of the smartest health care analysts in America acknowledges that the $2500 doesn't translate into reduce premiums:

Obama health adviser Cutler confirmed that the campaign's $2,500 per family projection doesn't represent only out-of-pocket savings for individual Americans. It includes savings to the government, employers and insurers, savings that could, Cutler says, trickle down to families in the form of lower taxes, higher wages or reduced premiums. In fact, Cutler says the $2,500 figure simply comes from dividing an overall savings estimate that's somewhat larger than $120 billion by an approximate number of four-person families in the U.S. "[W]e take the total and divide by the total population, then consider a 4 person family,"

Read More



Barack Obama:

“I happen to be a proponent of a single payer universal health care program.” (applause) “I see no reason why the United States of America, the wealthiest country in the history of the world, spending 14 percent of its Gross National Product on health care cannot provide basic health insurance to everybody. And that’s what Jim is talking about when he says everybody in, nobody out. A single payer health care plan, a universal health care plan. And that’s what I’d like to see. But as all of you know, we may not get there immediately. Because first we have to take back the White House, we have to take back the Senate, and we have to take back the House.”

Barack Obama on single payer in 2003

Guess what

Mammograms: 88.6% of American females 40-69 had ever had a mammogram compared to 72.3% of Canadians.
Women are ten percent less likely to survive five years with a breast cancer diagnosis in Canada and 20 percent more likely to die from breast cancer in Canada. If rates were adjusted for race and stage the difference would likely be higher.

Though the breast cancer drug Herceptin was approved in 1998 it was first used in Canada in 2005 and even then it's access to high responders was rationed.

Read more here


Change we -- and women with breast cancer -- don't need.




Pink Ribbon Reality

  • 10.07.2008
Will healthcare be discussed during tonight's presidential debate?  Smart money says "yes."

So does hopeful money -- since October is Breast Cancer Awareness Month.

That being the case, which candidate deserves to wear the Pink Ribbon?

A few questions to consider before answering:

Which candidate supports a platform that would accelerate the pharmaceutical community and the FDA down the Critical Path? 

Which candidate supports a program that believes in getting women with breast cancer the most appropriate care as early in their disease state as possible?

Which candidate supports a program that understands the value of incremental innovation and the "price/value" equation?

Will either candidate speak up for "the four rights" -- the right medicine for the right patient in the right dose at the right time?

Will either candidate wear a pink ribbon tonight?

Will either candidate wear a pink ribbon for reasons other than optics?

Legends of the Fall

  • 10.06.2008

Barak Obama's campaign released a horribly misleading ad about McCain's health care proposals, claiming that it would lead to millions losing health care coverage, raise taxes and hand over cash to insurance companies. 

The claims have failed every fact-check – from CBS
[1] to the Washington Post.[2] John McCain is not going to raise taxes on middle class families....

Transforming The Tax Code To Create Greater Equity:
The McCain plan transforms the current tax code to provide all American families – including the self-employed and the uninsured – the same tax benefit, a $5,000 refundable tax credit ($2,500 for individuals) that was previously only available to those with employer coverage. Families can use this credit to purchase insurance of their choice, including keeping their current coverage. This is an approach supported by Barack Obama's own Senior Economic Advisor Jason Furman who wrote that "we could scrap the current deduction altogether and replace it with progressive tax credits that, together with other changes, would ensure that every American has affordable health insurance."
[3]

·         Better Than "Members of Congress":  Under the McCain Plan, your employer can provide you with health insurance  as good as a "Member of Congress", and you would pay no  more in taxes – regardless of your tax bracket.  In fact, you would have some additional money left over from the McCain tax credit to put in a health savings account.

·         On The Issue Of the Congressional Plan – There Are Options, But All Are Under The FEHB Program: A good example is the Blue Cross and Blue Shield Service Benefit Plan, which has combined monthly premiums for family coverage of $1027.95, for an annual cost of $12,335.40.

 

Income Tax Liability

McCain Tax Credit

TOTAL Tax Savings

10% Bracket (Up to $15,650)

 

$1,200 ($12,000 x 10%)

$5,000

+$3,800

15% Bracket

($15,650 -63,700)

$1,800 ($12,000 x 15%)

$5,000

+$3,200

 

25% Bracket

($63,700-128,500)

 

$3,000 ($12,000 x 25%)

$5,000

+$2,000

 

28% Bracket

($128,500-195,850)

 

$3,360 ($12,000 x 28%)

$5,000

+$1,640

 

33% Bracket

($195,850 -349,700)

 

$3,960 ($12,000 x 33%)

$5,000

+$1,040

 

35% Bracket (349,700 and over)

 

$4,200 ($12,000 x 35%)

$5,000

+$800

 

·         Where Is The Middle-Class "Tax Increase"?   If you or your family is in the 28% bracket, with an income of $180,000, you could receive employer provided health insurance even better than a Member of Congress, with a cost of almost $18,000, with no increase in taxes. Even the liberal leaning Tax Policy Center, agrees that the McCain proposals will result in a "net tax benefit" of more than $1,200 for an average tax payer.[4]   

·         Helping Those Without Employer Coverage:  If you are a  middle-class American today without employer provided health care, the McCain plan would give you a tax credit of $2,500 as an individual, or $5,000 for a family, to help you buy your own health insurance coverage, including across state lines. American families – not government bureaucrats or insurance companies – will choose the coverage that best meets their needs.  Today, the government does nothing to help you.  Why does Barack Obama oppose this?

·         McCain Health Plan Puts Families in Charge: In another desperate attack, Barack Obama and Joe Biden have said that McCain health care tax credits to help families buy coverage "will go straight to the insurance company." Here is what they fail to mention – the credit goes to the insurance company that the American family chooses to get coverage from, anywhere in the nation. The power of choice lies with the family – not government bureaucrats or insurance companies.  Ridiculing this line of strange attack, The Associated Press stated, "Of course it would, because it's meant to pay for insurance. That's like saying money for a car loan will go straight to the car dealer."[5] Furthermore, any additional money left over after purchasing coverage will be controlled by the family in a portable health savings account.

·         McCain Health Care Plan Protects Our Vulnerable Population: John McCain believes that no American should be denied access to quality and affordable coverage simply because of a pre-existing condition. As President, John McCain will work with governors to develop a best practice model that states can follow – a Guaranteed Access Plan or GAP – that would reflect the best experience of the states to ensure these patients have access to health coverage.[6] There would be reasonable limits on premiums, and assistance would be available for Americans below a certain income level.[7]

·         McCain Health Care Plan Gives American Families More Choices: John McCain believes that American families should be given more choices by allowing them to purchase policies across state lines. In a move derided by fact checking organizations including Fact Check, the Obama campaign used this as an opportunity to falsely accuse John McCain of deregulating health care markets akin to Wall Street.[8] A recent study showed that simply allowing Americans to purchase across state lines would reduce the number of uninsured by almost 12 million.

·         McCain Health Care Plan Preserves Employer Coverage: The McCain health plan builds on the employer-based system. Employers will have the same incentive to provide health insurance as they do today since they will continue to deduct the cost of health insurance they provide to employees. Nothing will change. In addition, payroll taxes will be protected from taxes under the McCain plan. Millions of American families with employer sponsored coverage in all tax brackets with the same coverage as a "Members of Congress" will now come out ahead with additional funds going into a portable health savings account. Importantly, younger and healthier employees with the McCain health care tax credit will have a bigger incentive to stay with the employers. For example, a 25-year-old employee in the 25 percent tax bracket with a $2,500 tax credit could either purchase a policy in the individual market for the same amount or stay with his employer plan and receive a $5,000 policy with an additional $1,250 to invest in a portable health savings account.  Why would people choose worse insurance and less money? Finally, the McCain plan through comprehensive cost-containment policies addresses the single biggest threat to employer coverage – rising costs.   

The truth about Senator Obama's health plan:

·         Barack Obama's Plan Continues The Push Toward Government-Run Healthcare: The Obama plan will create a brand new government-run health plan at the cost of $243 billion a year – a financial burden of more than $3,000 a year on American families.[9]

·         Barack Obama's Plan Will Harm Employer Coverage: The Obama plan includes a $179 billion a year employer mandate.[10]  The mandate requires employers to either provide "meaningful" coverage or pay a tax towards the government plan.[11]  Faced with tough economic conditions and rising health costs this creates a clear incentive for employers to drop coverage and move families into the new government plan. A Lewin Group study which examined a similar employer mandate combined with a national plan, like the Obama plan, concluded that almost 52 million individuals would lose their private employer coverage.[12] To maintain their competitive edge, others employers will follow - spelling the demise of the employer coverage system.

·         Barack Obama's Plan Will Damage Private Coverage: The government-run plan will have a clear advantage over private insurance since it will be subsidized by American taxpayers. A recent analysis of both plans by the nonpartisan CATO Institute concluded that the Obama government-run plan will be able to "keep its premiums artificially low…since it can turn to the U.S. Treasury to cover any shortfalls" resulting in "undercutting the private market."[13] According to Wall Street Journal, the goal of the Obama plan "…like HillaryCare in the 1990s, is to displace current private coverage and switch people to the default government option."[14]  

Interesting story in today’s New York Times. Here’s how it begins:

"A new study suggests that free drug samples, an effective marketing tool for the drug industry, do little to help the poor and may put children’s health at risk.”

“… do little to help the poor …”   Really? 

No.  According to the report (published today in Pediatrics), once in a doctor’s office, children who do not have health insurance are more likely to receive free drug samples than children with health insurance. And here's the important context part --
children in the lowest income group were no more likely to receive the samples than were those in the highest income group, in part because the poor are less likely to see doctors.

So how do free samples “do little to help the poor?”
  Is there some sort of socio-economic biomarker we need to know about?

Skip to next paragraphBut, “… of greater concern, the authors wrote, are the kinds of drug samples that physicians provide.”  Indeed, the issue of pediatric safety is an important one, but all drugs have risks as well as benefits -- and the Precautionary Principle isn't going to help poor kids get better any faster.  But what it will do is create even wider health disparities.   It's also important to note that the report does not conclude that free samples are causing pediatricians to inappropriately prescribe anything. 

According to the Times, “The study’s lead author, Dr. Sarah L. Cutrona, an instructor at HarvardMedicalSchool, said in an interview that the drugs provided as free samples tended to be the newest, so their safety had often not been thoroughly vetted.”

Hey, what about all those generic sampling progams?

The Times interviewed Dr. Andrew Racine, director of general pediatrics at the Children’s Hospital at Montefiore in the Bronx.  He believes that free samples distort doctors’ decision-making. According to Dr. Racine, “This is just a marketing technique.”

Of course sampling is a marketing technique. But does this make sampling deliterious to pediatric health?  That’s the implication (the headline of the story is "Study says Drug Samples May Endanger Children"). 

"Just" a marketing technique?  What about the therapeutic benefits?

Another pediatrician interviewed by the Times, Dr. Lisa Asta of Walnut Creek, CA, said she's considering banning free samples from her practice because the drugs being promoted generally required high co-payments.

This is another important issue – but the answer is not to provide second class care to one cohort of children and a higher quality of care to another.  And banning samples doesn’t make things better -- it exacerbates the problem.

Click here for the complete story in today’s New York Times.

 

Mass Insanity

  • 10.06.2008

Last month two Massachusetts scientists won the Albert Lasker Medical Research Award. Commonly called "America's Nobel Prize," the Lasker Award is the country's most prestigious honor for medical breakthroughs. It was given to BayState biologists for their work on gene expression, the results of which show unprecedented promise in the efforts to combat disease.

The win is a testament to the strength of Massachusetts' medical research community. Yet local legislators have recently instituted a law likely to undermine the inter-industry partnerships essential to just this sort of cutting-edge scientific discovery.

In August, Gov. Deval L. Patrick signed a bill requiring pharmaceutical firms to report to state officials any payments over $50 made to physicians, academic scientists, or other medical professionals. The information - including the names of the people getting paid - will be posted on a public Web site. The bill goes into effect Jan. 1, and provides for fines of up to $5,000 for non-compliance.

This disclosure law is supposed to increase transparency. State officials are understandably worried that money from drug makers could unduly influence research results or physicians' practices. And they want to ensure that patients know if their healthcare provider has a financial incentive to recommend certain treatments.

 
But publishing this information suggests that there is something wrong with medical professionals working with the pharmaceutical industry. There isn't.

Physicians rely on drug makers for up-to-date information about new treatments. Drug makers in turn rely on doctors for feedback on the real-world clinical effects of their pills - the kind of information that can't be acquired in a laboratory.

The law is also unnecessary. This summer, the drug industry announced strict new limits on sales personnel, banning them from buying lavish meals or giving gifts of any sort during meetings with physicians. Since physicians are often only available for non-patient work during lunchtime, sales reps will only be allowed to pay for the occasional modest meal at a doctor's office, as long as it's "in conjunction with informational presentations."

And under the new guidelines, sales reps are strictly prohibited from passing along information that is anything other than educational.The BayState's disclosure law will stigmatize the doctors it publicizes. Many might leave Massachusetts in favor of a state with a healthier regulatory environment. That would make a bad situation worse: Nearly a quarter of the state's physicians are already considering leaving or are planning to leave because of legal controls on clinical practices, according to a Massachusetts Medical Society report.

The law will also have a dampening effect on academic medical research.

Funds provided by private firms don't compromise lab work they're essential to getting the research off the ground in the first place. Many of Massachusetts' academic medical centers are currently conducting research in partnership with pharmaceutical companies.Scientists are likely to give up on research projects that require corporate sponsorship for fear of jeopardizing their reputations.

Biopharmaceutical companies employ around 55,000 Massachusetts residents, according to the Center for Labor Market Studies at Northeastern University. If researchers start leaving the state to avoid stigmatization, investment dollars and jobs will follow. And that means fewer breakthrough cures from the commonwealth.

Ironically enough, this law's passage comes at a time when state legislators are making a concerted effort elsewhere to bolster the BayState's medical research industry. In June, Gov. Deval L. Patrick approved a 10-year, $1 billion biotechnology initiative, meant to expand investment in state-level research projects.

This new disclosure law hinders those efforts. It will stifle life science innovation, choke off investment dollars into new cures, and destroy medical sector jobs. Patients, physicians, researchers, and average citizens alike should be outraged.

Mighty Joe Antos

  • 10.04.2008
Check out our latest video podcast featuring the brutally honest observations of AEI's Joe Antos.

Check
here and then click on the smart looking guy in the maroon-striped tie.

Here's a taste, "We have to stop walling-off reality when it comes to discussing healthcare reform."

Say it ain't so, Joe.

It seems that Sarah Palin isn't the only target for Katie Couric and CBS News...

In recent years Katie and her crew have gone after vaccine makers and the make believe link between vaccines and autism, taking up the cause of trial attorneys on the one hand and glossing over the scientific data demonstrating no relationship on the other...

Back in June 2007, “CBS Evening News” featured a story titled “Vaccines suspected in rise in autism rates.” CBS News correspondent Sharyl Attkisson reported on the hardships of the parents of an autistic child and their fight to win money from a federal fund for “vaccine damages.”

“Twelve-year-old Michelle Cedillo doesn't know it, but she's the center of a landmark case that started today in federal vaccine court, one that could open the door for thousands of autistic children to be paid by a government fund,” Attkisson said on the June 11, 2007, “CBS Evening News.” “The controversy: whether their autism was caused by their childhood shots.”

Seven months later, the study, supported through the California Department of Public Health according to a press release, got little fanfare. It got only a brief mention on “CBS Evening News,” despite CBS airing six stories over the past two-and-a-half years that sounded alarm bells over thimerosal, according to a Nexis search.

One CBS story, aired on July 15, 2005, included the ranting and ravings of environmental extremist Robert F. Kennedy, Jr. “The science connecting brain damage with thimerosal is absolutely overwhelming,” Kennedy said.

See here.

In June of 2008, Attkisson was at it again, this time trying to discredit scientists and organizations who support immunization because they receive support from vaccine companies (ignoring the fact that Robert F Kennedy and others she provided fawning coverage for are on the trial attorney take...) Here's the lead into a story on Katie's show one month after the California study came out:

"For years some parents and scientists have raised concerns about vaccine safety, including a possible link to autism and ADD. Many independent experts have sided with government officials and other scientists who say there's no possible connection. But how "independent" are they? "

http://www.cbsnews.com/stories/2008/07/25/cbsnews_investigates/main4296175.shtml

Now it turns out that Katie is bringing another reporter into her stable with close ties to trial attorneys whose history is writing about health litigation issues – principally sourced from class action litigators, Heather Won Tesoriero.

Heather Won Tesoriero is brand new to CBS and this is probably working now on her very first stories. At the beginning of September she joined a leading talent agency ( N.S. Bienstock) which helped her move from medical and law reporter at the Wall Street Journal to CBS NEWS as a field producer covering medical issues. It appears she’s trying to make a big leap and name for herself with Katie Couric. Will CBS and Couric become the latest platform for Tesoriero’s history of big class action law firm-sourced attacks? If Atkisson's autism crusade is any indication what's to come, the answer is yes.

While a WSJ staff health reporter and blogger she primarily focused on medical-related fraud/litigation issues and is clearly well-connected to the plaintiff’s attorneys side quoting their claims and interviewing them unchallenged on WSJ-TV. She was “co-counsel” for the WSJ Law Blog. She’s done several reports on drug side effects (clearly promoted by class action litigators), some environmental-linked health claims and other purported health fraud topics. No one should be surprised if she brings the same sources, bias and unbalanced reporting to CBS.

Links to other related stories written by Tesoriero on behalf of class action litigators:

· Oil Firms Settle Claims In MTBE Leak Cases – article

· Video interview with plaintiff attorney by Tesoriero on MTBE leak

· Patients Sue Icelandic Drugmaker Over Recalled Heart Drug

· Health-Care Fraud: Keep an Eye on the Small Fry

· Wayward Medical Records Sold as Scrap Paper for $20

· Whistleblower Law Blog: Tesoriero and quitam lawsuit

· Vioxx Study Casts Doubt on Merck Claim


Only a small margin of voters believe that Obama's health plan will benefit them personally compared to McCain's plan.

See here.

So along comes the supposedly non partisan Commonwealth Fund with a report claiming that the Obama plan will do a better job in reducing the number of people without health insurance.

See here.

Unfortunately media reports ignore the fact that the Commonwealth Fund also produced a study this past summer "demonstrating" that something like the Obama plan would only cost $165 billion over ten years and touted the features of the Obama plan including a National Health Exchange, expanding Medicaid, subsidies for large corporations, etc.

See here.

Nothing like using the media to pass on a favorable review of your own proposal and as a springboard to jump into the tank with Obama.

Fake Drugs ToGo

  • 10.03.2008

From the New York Times:

Belgium: Shipments of Fake Pills Seized

Customs officers at the Brussels airport seized more than two million counterfeit pills on Thursday that were made in India and destined for Africa, officials said. Blister packs of the pills, above, which included counterfeits of Tramal, a painkiller, and of Fansidar, an antimalaria drug, were found in large bags, the customs service said in a statement. The pills were sent in three shipments by a company based in Mumbai and were bound for two companies in western Africa. Lieven Muylaert, spokesman for the Belgian customs department, told Agence France-Presse, “To our knowledge, this is the biggest seizure of counterfeit medicine ever carried out in Europe.”

From the BBC:

Belgians seize Africa-bound drugs

More than two million counterfeit drugs destined for Africa have been seized in Belgium, customs officials say.

They said the shipment from India, including copies of an anti-malaria drug, was the biggest seizure of fake medication ever made in Europe.

Customs officers at Brussels airport became suspicious when they noticed spelling mistakes on the labels.

 The UN says fake medicines represent 10% of the world market and up to 30% of the African market.

The seizure, made last week, was made public on Thursday night.

Hidden in large bags, the pills were copies of a strong painkiller made by a German company, and a Swiss-made anti-malarial treatment.

The confiscated medicines had been sent in three shipments by an Indian company in Mumbai, and were bound for two unnamed companies based in Togo.

Belgium's Le Soir newspaper reported that the drugs were probably intended to be distributed across West Africa.

"Thanks to this seizure, we have saved lives," Le Soir quoted Lieven Muylaert, spokesman for Belgium's customs department, as saying.

CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog